FindTrial
Sign In

Using Home Blood Pressure Monitoring to Improve Blood Pressure Control in People with Chronic Kidney Disease

The Effectiveness of Telemonitoring in Controlling Hypertension in Chronic Kidney Disease THICK study a randomized controlled trial - THICK study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101360
Enrollment
526
Registered
2026-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)

Interventions

Intervention1: combined automated office blood pressure monitoring (AOBPM) and telemonitoring of home blood pressure measurement: In the telemonitoring group, participants will be required to fill out

Sponsors

Council of Science & Technology UP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Eligible patients aged 18 to 65 years with a diagnosis of hypertension office BP 140 to 179systolic and 90 to 109mmHg diastolic with mean 24 h BP determined using ambulatory BP monitoring of more than or equal to 130mmHg before enrolment will be recruited in the study Participants should be able to use a smartphone Only patients of chronic kidney disease in stages 3 and 4 will be included in the study

Exclusion criteria

Exclusion criteria: Office SBP more than or equal to 180 mmHg and or DBP more than or equal to 110 mmHg Suspected secondary hypertension other than renoparenchymal Pregnancy active neoplasia Congestive heart failure

Design outcomes

Primary

MeasureTime frame
to compare the mean change in systolic blood pressure in patients with chronic kidney disease stages 3 and 4 undergoing office blood pressure (BP) and home blood pressure telemonitoring compared to office blood pressure measurement from baseline to 24 weeks.Timepoint: to compare the mean change in systolic blood pressure in patients with chronic kidney disease stages 3 and 4 undergoing office blood pressure (BP) and home blood pressure telemonitoring compared to office blood pressure measurement from baseline to 24 weeks.—

Secondary

MeasureTime frame
to compare the mean change in diastolic blood pressure in patients with chronic kidney disease stages 3 and 4 undergoing office BP and home blood pressure telemonitoring compared to office blood pressure measurement from baseline to 24 weeks.Timepoint: 24weeks;to compare the change in medication adherence using the Morisky scale in CKD stages 3 and 4 patients undergoing office and home BP telemonitoring to only office BP measurement from baseline to 24 weeksTimepoint: 24weeks—

Countries

India

Contacts

Public ContactABHILASH CHANDRA

Dr RMLIMS

acn393@gmail.com08176007206

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026